Novel and old entities

Thematic Poster
Chairs: R. Baughman (Cincinnati, United States of America), W. Wuyts (Rotselaar, Belgium), J. Grutters (Nieuwegein, Netherlands)

Interstitial pneumonia with autoimmune features: applying novel diagnostic criteria to an existing patient cohort. H. Hall (Surrey, United Kingdom)
Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF) Y. Mori (Seto, Aichi, Japan)
Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease I. Wiertz (Utrecht, Netherlands)
Minor salivary gland biopsy in patients with IPAF and suspected Sjogren’s syndrome. P. Millan Billi (BARCELONA, Spain)
Prevalence and clinical characteristics of unclassifiable idiopathic interstitial pneumonias (IIPs) C. Rotenberg (Paris, France)
Metamorphosis of idiopathic interstitial pneumoniae (IIPs). Y. Ilkovich (ST PETERSBURG, Russian Federation)
Echocardiographic parameters in suspected cardiac sarcoidosis patients-the role of speckle tracking strain analysis in the diagnosis of cardiac sarcoidosis V. Kouranos (London, United Kingdom)
INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURE (IPAF): Clinical, radiological and morphologic profile in indian patients. S. Chaurasia (BANGALORE (KARNATAKA), India)
HLA-C*2 as a new HLA marker of Granulomatosis with Poliangiitis. C. Barbas (Sao Paulo/Sp, Brazil)
A case-series of Brazilian patients with Granulomatosis with poliangiitis C. Barbas (Sao Paulo/Sp, Brazil)
Association between ANCA positivity and HLA genotyping in Brazilian patients with Granulomatosis with Polyangiitis. C. Barbas (Sao Paulo/Sp, Brazil)
Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease S. Majdoub Fehri (ARIANA, Tunisia)
Screening of ?ardiac involvement in sarcoidosis D. Zhurkin (Minsk, Belarus)
Identifying Inflammatory Myopathies to optimise Interstitial lung disease treatment strategies> A. O'Mahony (Co. Cork, Ireland)
Small airways impairment and air-trapping in patients with chronic hypersensitivity pneumonitis (CHP) of different severity M. Bonini (London, United Kingdom)
Impact of phenotyping/flow cytometry technique on CD4/CD8 index examination in lung granulomatous diseases (LGD) P. Kopinski (Bydgoszcz, Poland)
A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). I. Campo (Pavia, Italy)
Detrended Fluctuation Analysis independently predicts all-cause mortality of patients with Sarcoidosis E. Gialafos (Athens Attiki, Greece)
Development of a multivariate model to predict clinical deterioration in pulmonary sarcoidosis M. Thillai (Cambridge, United Kingdom)
Noninvasive Arterial Stiffness Measurement in Patients with Sarcoidosis E. Demirdogen Cetinoglu (Bursa, Turkey)